Quality-by-design (QbD): an integrated multivariate approach for the component quantification in powder blends
Huiquan Wu1, Mobin Tawakkul, Maury White
1Division of Product Quality Research , OTR/OPS/CDER/FDA, FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. huiquan.wu@fda.hhs.gov
International Journal of Pharmaceutics
|May 14, 2009
Summary
This study presents a multivariate approach using near-infrared (NIR) spectroscopy to quantify drug and excipient concentrations in powder blends. The developed models accurately predict major component levels, highlighting the importance of understanding excipient variability for blending homogeneity.
Area of Science:
- Pharmaceutical Sciences
- Analytical Chemistry
- Chemometrics
Background:
- Accurate quantification of drug and excipient concentrations is crucial for pharmaceutical product quality and efficacy.
- Traditional methods for analyzing powder blends can be time-consuming and may not provide real-time monitoring.
- Developing integrated, multivariate approaches can enhance the efficiency and accuracy of blend analysis.
Purpose of the Study:
- To develop and validate an integrated multivariate approach for quantifying drug and excipient concentrations in powder blends.
- To compare the predictive performance of Near-Infrared (NIR) spectroscopy with UV-Vis spectroscopy for blend analysis.
- To investigate the impact of component concentration on prediction accuracy and measurement uncertainty.
Main Methods:
- A mixture design was employed with 26 formulations of ibuprofen (drug) and three excipients (HPMC, MCC, Eudragit L100-55).
- Near-infrared (NIR) spectral data and UV assay data were collected at various time points during powder blending.
- Multivariate calibration models, including Partial Least Squares (PLS), Principal Component Regression (PCR), and Multiple Linear Regression (MLR), were established using Savitzky-Golay 1st derivative NIR spectra.
Main Results:
- PLS models effectively predicted the concentrations of main components in powder blends using both NIR and UV data.
- Prediction errors were found to be larger for minor components, consistent with Complete Random Mixture (CRM) model expectations.
- Measurement uncertainties were higher for minor components, indicating a greater variability in their quantification.
Conclusions:
- The developed multivariate NIR approach provides a viable method for quantifying constituent concentrations in powder blends.
- Understanding excipient variability is critical for assessing powder blending homogeneity and ensuring product quality.
- Differences in prediction performance between NIR and UV models are attributable to the scale of scrutiny and model applicability.
Related Concept Videos
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:28Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
01:19Quality Assurance
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...